Actym Therapeutics, which named a new CEO earlier this year, has appointed Mary J. Janatpour, PhD, as Chief Scientific Officer and Shouryadeep “Deep” Srivastava, MD, PhD, as Senior Vice President of Clinical Development.   Dr. Janatpour and Dr. Srivastava bring extensive therapeutic product discovery and development expertise as Actym continues the clinical advancement of its lead program and expands its portfolio of drug candidates.   “We are fortunate to attract exception...